Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma
Wenping Lin(Sun Yat-sen University), Rong Guo(Sun Yat-sen University), Yihong Ling(Sun Yat-sen University), Kaili Xing(Sun Yat-sen University), Wu-Shen Yu(Dongguan People’s Hospital), Wei Wei(Zhujiang Hospital), Shaohua Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhiyuan Chen(Wuhan University), Jiahong Wang(Guangzhou Medical University), Lianghe Lu(Sun Yat-sen University), Yongfa Zhang(Taiyuan University of Technology), Jianchang Fu(Sun Yat-sen University), Chong Zhong(Guangzhou University of Chinese Medicine)
Cited by 65
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
|European Journal of Endocrinology|2011|160